Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol disodium phosphate vs propofol for postoperative transport and ICU sedation in critically ill patients
ChiCTR2500095758Phase 4Not yet recruiting
- Sponsor
- Tianjin Nankai Hospital
- Start
- Jan 2025
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fospropofol disodium and propofol in critical illness (2 arms), sponsored by Tianjin Nankai Hospital. Primary endpoint: Sedation success rate during postoperative transportation. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
fospropofol disodiumpropofol
03
Conditions
critical illness
Beyond the preview
Go deeper on ChiCTR2500095758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095758.